Related Experiment Video
Updated: Jul 14, 2026
05:56
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
Asthma treatment: 'magic bullets which seek their own targets'
F Tarantini1, I Baiardini, G Passalacqua
1Allergy and Respiratory Diseases, DIMI--University of Genoa, Genova, Italy.
Allergy
|May 19, 2007
Summary
Monoclonal antibodies offer new asthma treatment options by targeting specific antigens. Anti-IgE therapy, like omalizumab, shows promise for allergic asthma by reducing exacerbations and improving quality of life.
Area of Science:
- Immunology
- Allergology
- Pharmacology
Background:
- Monoclonal antibodies represent a significant advancement in treating allergic diseases.
- Understanding the efficacy and safety profiles of various targeted therapies is crucial.
Purpose of the Study:
- To review different therapeutic strategies targeting molecules in the allergic cascade.
- To evaluate the effectiveness and risks associated with these novel asthma treatments.
Main Methods:
- Analysis of various molecular targets including CD4, TNF-alpha, IL-4, IL-5, IL-10, IL-12, endothelial adhesion molecules, and IgE.
- Focus on omalizumab, a monoclonal antibody targeting IgE.
Main Results:
- Various monoclonal antibodies demonstrate potential in interfering with allergic reactions.
- Omalizumab (anti-IgE) shows significant benefits in reducing asthma exacerbations and improving quality of life.
- High cost and specific patient subset limitations exist for omalizumab.
Conclusions:
- Anti-IgE therapy, exemplified by omalizumab, is a highly effective treatment for a subset of allergic asthma patients.
- Omalizumab offers a favorable safety profile and improves patient outcomes.
- Further research into cost-effectiveness and broader applicability is warranted.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...